New York, Jan 2, 2026, 20:47 ET — Market closed
- Confluent shares ended down 0.4% at $30.11, just under IBM’s $31-per-share cash offer
- The narrow discount keeps attention on deal timing, approvals and the interest-rate backdrop
- Next catalysts include U.S. jobs data (Jan. 9), CPI (Jan. 13) and the next milestone in the merger process
Confluent, Inc. (CFLT) shares closed down 0.4% at $30.11 on Friday, ending the first trading day of 2026 just under IBM’s $31-per-share cash offer. IBM has said the all-cash acquisition values Confluent at an enterprise value of $11 billion, is expected to close by mid-2026, and has support agreements from investors controlling about 62% of Confluent’s voting power.
The stock’s small discount to the offer price is the metric merger-arbitrage traders watch. Merger arbitrage is a strategy of buying a takeover target to capture the gap to the deal price if the transaction closes.
That gap can widen or narrow with shifts in risk appetite and the interest-rate outlook, which change the return investors demand for waiting on a cash deal. U.S. stocks finished mixed on Friday, and the market is seeing a “buy the dip, sell the rip” trading mentality, said Joe Mazzola, head of trading and derivatives strategist at Charles Schwab. Reuters
Confluent sells software that streams data in real time — a plumbing layer companies use to keep applications, analytics and AI models fed with fresh information. Its platform is built around Apache Kafka, an open-source framework for moving data between systems.
With IBM’s offer fixed, the $31 deal price acts as the anchor for trading and limits upside unless a competing proposal emerges. The swing factor is perceived completion risk, including regulatory scrutiny and the time it takes to get to a shareholder vote.
Investors in cash takeovers also keep an eye on financing costs. When rates rise, the same dollar spread translates into a lower annualized return for holding the position until closing.
Before the next U.S. session, investors face a calendar that can move yields and, by extension, cash-deal spreads: the December jobs report is due Jan. 9 and the consumer price index follows on Jan. 13, alongside the start of fourth-quarter earnings season led by major banks such as JPMorgan on Jan. 13.
Company-specific catalysts are limited until the deal process advances, but earnings remain a potential waypoint if the transaction stretches out. Confluent has not confirmed its next reporting date; MarketBeat estimates Feb. 10 based on prior patterns, and investors typically track subscription growth and cloud revenue mix as the core gauges of momentum.
Technically, the math is straightforward: $31 is the lid, and $30 is the nearby reference point after Friday’s close. A move materially below $30 would likely signal rising doubts about the closing path rather than a shift in quarterly fundamentals.
Traders will also watch for any new filings that firm up the timetable for a shareholder meeting and for signs of progress in regulatory review. In a deal stock, those milestones tend to matter more than day-to-day market swings.
Until there is new information on approvals, vote timing or market rates, Confluent is likely to keep shadowing the $31 offer price — with the discount acting as the market’s real-time scorecard on confidence and patience.
Related articles: NYSE:IBM
